financetom
Technology
financetom
/
Technology
/
What Analysts Are Saying About Palantir Technologies Stock
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What Analysts Are Saying About Palantir Technologies Stock
Nov 4, 2025 4:09 AM

Ratings for Palantir Technologies ( PLTR ) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 1 1 0 0
Last 30D 1 0 0 0 0
1M Ago 0 1 1 0 0
2M Ago 1 0 0 0 0
3M Ago 0 0 0 0 0

In the assessment of 12-month price targets, analysts unveil insights for Palantir Technologies ( PLTR ), presenting an average target of $215.25, a high estimate of $255.00, and a low estimate of $190.00. Observing a 14.19% increase, the current average has risen from the previous average price target of $188.50.

Interpreting Analyst Ratings: A Closer Look

The analysis of recent analyst actions sheds light on the perception of Palantir Technologies ( PLTR ) by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Mariana Perez Mora B of A Securities Raises Buy $255.00 $215.00
Tyler Radke Citigroup Raises Neutral $190.00 $177.00
Clarke Jeffries Piper Sandler Raises Overweight $201.00 $182.00
Mariana Perez Mora B of A Securities Raises Buy $215.00 $180.00

Key Insights:

Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Palantir Technologies ( PLTR ). This information offers a snapshot of how analysts perceive the current state of the company.

Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Palantir Technologies ( PLTR ) compared to the broader market.

Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Palantir Technologies's ( PLTR ) market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Palantir Technologies ( PLTR ) analyst ratings.

Delving into Palantir Technologies's ( PLTR ) Background

Palantir ( PLTR ) is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir ( PLTR ) works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.

Key Indicators: Palantir Technologies's Financial Health

Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.

Revenue Growth: Palantir Technologies's ( PLTR ) revenue growth over a period of 3M has been noteworthy. As of 30 June, 2025, the company achieved a revenue growth rate of approximately 48.01%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.

Net Margin: Palantir Technologies's ( PLTR ) net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 32.55%, the company may encounter challenges in effective cost control.

Return on Equity (ROE): Palantir Technologies's ( PLTR ) financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.76%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Palantir Technologies's ( PLTR ) ROA stands out, surpassing industry averages. With an impressive ROA of 4.63%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Palantir Technologies's ( PLTR ) debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.04.

How Are Analyst Ratings Determined?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis
Oct 21, 2025
SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics ( SION ), Inc. , a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the...
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
Oct 21, 2025
The investment enhances German facility to deliver more flexible and scalable drug delivery solutions PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced a significant expansion of its drug delivery system manufacturing capacity, further strengthening its global footprint to...
Lightbridge to Hold Business Update & Third Quarter 2025 Earnings Conference Call on Thursday, November 6 at 4 p.m. ET
Lightbridge to Hold Business Update & Third Quarter 2025 Earnings Conference Call on Thursday, November 6 at 4 p.m. ET
Oct 21, 2025
RESTON, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation ( LTBR ) (“Lightbridge” or the “Company”) , an advanced nuclear fuel technology company, will announce its financial results for the third quarter of fiscal year 2025 on Wednesday, November 5, after the market closes. Lightbridge ( LTBR ) will host a conference call on Thursday, November 6, at 4:00...
European third-quarter corporate outlook worsens slightly
European third-quarter corporate outlook worsens slightly
Oct 21, 2025
By Javi West Larrañaga and Marleen Kaesebier Oct 21 (Reuters) - The outlook for European corporate health has slightly worsened, the latest earnings forecasts showed on Tuesday. European companies are expected to report an increase of 0.2% in third-quarter earnings, on average, according to LSEG I/B/E/S data, below the 0.5% growth analysts were expecting a week ago. That would be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved